Brief: Evoke Pharma Reports Record Third Quarter 2022 Financial Results
09/11/2022 21:41
Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA REPORTS RECORD THIRD QUARTER 2022 FINANCIAL
RESULTS
* EVOKE PHARMA INC Q3 LOSS PER SHARE $0.60
* EVOKE PHARMA-BELIEVES EXISTING CASH, CASH EQUIVALENTS,
ANTICIPATED FUTURE CASH FLOWS FROM SALES OF GIMOTI, SUFFICIENT
TO FUND OPERATIONS INTO Q2 2023
Source text for Eikon: ID:nGNX2CYqt8
Further company coverage: EVOK.O
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary